Global Haptoglobin Reagent Market Size study, By Product Type (Buffer Reagent, Antiserum Reagent, Others}, By End User (Hospital, Specialty Clinics, Diagnostic Laboratory, Others), and Regional Forecasts 2022-2028

Global Haptoglobin Reagent Market Size study, By Product Type (Buffer Reagent, Antiserum Reagent, Others}, By End User (Hospital, Specialty Clinics, Diagnostic Laboratory, Others), and Regional Forecasts 2022-2028

Global Haptoglobin Reagent Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Haptoglobin reagents are used for haptoglobin protein measurements. These are used in the diagnosis of haemolytic anaemia and to separate it from different types of anaemia. Growing number of hematology testing procedures and increasing global prevalence of anaemia are driving the growth of Haptoglobin Reagent Market. For instance, according to Statista – In 2018, the global hematology testing market was estimated at USD 4.5 billion. It is projected to reach to USD 8.2 billion by 2029. Furthermore, according to the Centers for Disease Control and Prevention, as of 2021, around 3 million people in the United States are suffering from anemia. Also, growing senile population worldwide and rising healthcare sector are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, lack of demand from developing economies due to minimal incidence of Haemolytic anemia impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Haptoglobin Reagent Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to increasing number of hematology testing procedure and presence of leading market players. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as rising healthcare infrastructure and growing number of geriatric populations in the region, would create lucrative growth prospects for the Haptoglobin Reagent Market across the Asia Pacific region.

Major market players included in this report are:
Sekisui Diagnostics
Randox Laboratories
Beckman Coulter Inc. (Danaher Corporation)
Kamiya Biomedical Company
Adaltis S.r.l.
SDIX, LLC
Lab Mark A.s
Abbott Laboratories
IBL International GMBH
Analytik Jena AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type
Buffer Reagent
Antiserum Reagent
Others
By End User
Hospital
Specialty Clinics
Diagnostic Laboratory
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Haptoglobin Reagent Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Sekisui Diagnostics
Randox Laboratories
Beckman Coulter Inc. (Danaher Corporation)
Kamiya Biomedical Company
Adaltis S.r.l.
SDIX, LLC
Lab Mark A.s
Abbott Laboratories
IBL International GMBH
Analytik Jena AG

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.